Which innovative launch strategy did Medtronic use for its MiniMed 670G, the world's first automated insulin delivery system ('artificial pancreas') for Type 1 diabetes patients?

In the competitive world of medical device and pharmaceutical launches, timing and strategy are everything. The healthcare industry faces unique regulatory challenges that can significantly impact product success. This trivia tests your knowledge about a famous medical product launch that revolutionized patient care while navigating complex industry requirements. Can you identify the correct launch strategy that made this groundbreaking product successful?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Immediate global rollout with simultaneous FDA and EMA approvals to maximize market share before competitors could respond
Phased launch with Priority Access Program for existing patients, allowing controlled market entry while gathering real-world data
Direct-to-consumer marketing campaign bypassing physician education, focusing on patient demand to drive adoption
Exclusive hospital-only distribution for the first year, restricting the technology to specialized diabetes centers